Lilly Ventures is the venture capital arm of pharmaceutical company, Eli Lilly. Lilly Ventures will look at early to expansion stage investments. Lilly Ventures currently has US$200 million under management and specifically targets opportunities i...Show all
Phone: (317) 651-3050
115 W. Washington Street
Suite 1680 - South
Indianapolis, 46204
Indiana, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-06-06 | Sutro Biopharma | Series E | $85.4M | Alta Partners, Amgen Ventures, Celgene, Citadel, Eventide Asset Management, Merck Ventures, Nexthera Capital, Samsara BioCapital, Skyline Ventures, SV Health Investors, Tekla Capital Management, and Vida Ventures |
| 2018-06-05 | Nimbus Therapeutics | Series C | $65M | Atlas Venture, Bill Gates, Lightstone Ventures, Pfizer Venture Investments, Schrodinger, and SR One |
| 2017-10-30 | Kymera Therapeutics | Series A | $30M | Amgen Ventures, and Atlas Venture |
| 2017-05-22 | Symic Biomedical | Series B | $30M | Alexandria Venture Investments, Ally Bridge Group, Den Danske Forskningsfond, Heda Ventures, InCube Ventures, Mission Bay Capital, Mitsui & Co. Global Investment, Purdue Foundry Investment Fund, and QB3 Garage |
| 2017-01-06 | Aileron Therapeutics | Series F | $30.11M | Apple Tree Partners, Excel Venture Management, and Novartis Venture Funds |
